Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis
Clinical trial NCT02903212 · UNKNOWN
Trial details
- NCT number
- NCT02903212
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-06-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.